ChromaDex Corp. (Los Angeles, CA) has announced that it has changed its corporate name to Niagen Bioscience, Inc. and trade under the new Nasdaq symbol “NAGE” effective at stock market open on Wednesday, March 19, 2025.
As part of this transition, the company will deploy a follow-up announcement with additional updates regarding the name change, rebrand and future initiatives.
No action is required by existing shareholders with respect to the ticker symbol change. The company’s common stock will continue to be listed on Nasdaq and the CUSIP will remain unchanged.
For more information, visit www.niagenbioscience.com.
